Table 2.
Characteristics of the studies evaluating oncological outcomes in patients with tumors < 2 cm.
| Author | Year | N | Outcomes |
|---|---|---|---|
| Nam, et al. [95] | 2012 | 526 (335 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Paik, et al. [101] | 2019 | 476 (248 < 2 cm) | Difference observed: MIS was associated with a lower rate of disease-free survival (DFS) |
| Kim, et al. [96] | 2019 | 565 (283 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Pedone Anchora, et al. [94] | 2020 | 423 (251 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Chen, et al. [103] | 2020 | 325 | Difference observed: MIS was associated with worse 5-year disease-free survival |
| Yang, et al. [97] | 2020 | 333 (111 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Chiva, et al. [90] | 2020 | 693 (303 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Uppal, et al. [99] | 2020 | 815 (264 < 2 cm) | Difference observed: MIS was associated with increased risk of recurrence and inferior disease-free survival |
| Rodriguez, et al. [98] | 2021 | 1379 (979 < 2 cm) | No difference between open surgery (OP) and minimally invasive surgery (MIS) for oncologic outcomes |
| Nasioudis, et al. [102] | 2021 | 2046 | Difference observed: MIS was associated with worse overall survival (OS) |